Biotech Values

[dewophile]

agree - just announcing a buyback would probably put a floor on the stock price. investing in a pipeline though would be better than paying 40% taxes if they found something worthwhile (obviously increases the risk profile but hey it's biotech!)
one thing i think enta should not invest much in is HCV. There just isn't enough room for improvement to make it worth the money. If they can get a drug that is complementary to abbvie's next gen combo quickly and sell them on it great, otherwise the money is better spent elsewhere IMO. in fact, if they were going to put serious dollars in HCV they should have opted into abt-493